1. Home
  2. Analysis
  3. Tequin
  4. Anastrozole

Tequin and Anastrozole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tequin (gatifloxacin) and Anastrozole (anastrozole). Common drug interactions include anaemia among females and drug toxicity among males.

The phase IV clinical study analyzes what interactions people have when they take Tequin and Anastrozole. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Tequin?

Tequin has active ingredients of gatifloxacin. eHealthMe is studying from 4,645 Tequin users. Check the latest studies of Tequin.

What is Anastrozole?

Anastrozole has active ingredients of anastrozole. It is often used in breast cancer. eHealthMe is studying from 21,892 Anastrozole users. Check the latest studies of Anastrozole.

On Jul, 16, 2026

23 people who take Tequin and Anastrozole together, and have interactions are studied.

Tequin and Anastrozole drug interactions.

What are the common drug interactions of Tequin and Anastrozole, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Impaired healing
  3. Localised infection (infection at the single location)
  4. Loose tooth
  5. Metastases to bone (cancer spreads to bone)
  6. Metastases to central nervous system (cancer spreads to central nervous system)
  7. Osteitis (a general term for inflammation of bone)
  8. Osteomyelitis (infection of bone)
  9. Osteosclerosis (an elevation in bone density)
  10. Swelling

male:

  1. Drug toxicity

What are the common drug interactions of Tequin and Anastrozole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Drug toxicity

50-59:

n/a

60+:

  1. Anaemia (lack of blood)
  2. Arthralgia (joint pain)
  3. Localised infection (infection at the single location)
  4. Loose tooth
  5. Metastases to bone (cancer spreads to bone)
  6. Metastases to central nervous system (cancer spreads to central nervous system)
  7. Osteitis (a general term for inflammation of bone)
  8. Osteomyelitis (infection of bone)
  9. Osteosclerosis (an elevation in bone density)
  10. Swelling

What are the existing conditions these people have? *

  1. Metastases To Bone (cancer spreads to bone): 20 people, 86.96%

* Approximation only. Some reports may have incomplete information.

Do you take Tequin and Anastrozole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tequin and Anastrozole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tequin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Anastrozole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tequin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Anastrozole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on gatifloxacin and anastrozole (the active ingredients of Tequin and Anastrozole, respectively), and Tequin and Anastrozole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.